DGAP-Adhoc: Pulsion Medical Systems SE: Downlisting

        Print
| Source: EQS Group AG
Pulsion Medical Systems SE  / Key word(s): Miscellaneous

25.06.2014 19:59

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------


Pulsion Medical Systems SE: Downlisting

Feldkirchen, 25.06.2014 

Pulsion Medical Systems SE today submitted an application for revocation of
admission of its shares to the Prime Standard following the decision of the
administrative board with regard to downlisting of May 15, 2014 as
announced ad-hoc. Further the company submitted an application for
revocation of admission of its shares to the regulated market. Both
applications were sent today to the management board of the Frankfurt Stock
Exchange (FWB).

The revocation of admission to the Prime Standard becomes effective  three
months after its publication by the management board of the FWB on the
Internet (www.deutsche-boerse.com). Such revocation has no impact on the
admission to the regulated market (General Standard).
 
The revocation of admission to the regulated market becomes effective
presumably six months  after its publication by the management board of the
FWB on the Internet (www.deutsche-boerse.com).
At that time the shares of Pulsion Medical Systems SE will be traded only
in the open market.

Important notice:

This information contains forward-looking statements that are based upon
current views and assumptions of Pulsion, which were made to its best
knowledge. Forward-looking statements are subject to known and unknown
risks, uncertainties and other factors. In consideration of these risks,
uncertainties and other factors, persons receiving these documents are
advised not to unreasonably rely on these forward-looking statements.




Contact:

Investor Relations
PULSION Medical Systems SE
Ralph Schäfer
Director Legal Affairs 
Tel.: +49 (0)89 / 459914 211 
Fax: +49 (0)89 / 459914 481 
E-mail: schaefer@pulsion.com


25.06.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Pulsion Medical Systems SE
              Hans-  Riedl-  Straße 21
              85622 Feldkirchen
              Germany
Phone:        +49 (0)89 4599 14-0
Fax:          +49 (0)89 4599 14-18
E-mail:       info@pulsion.com
Internet:     www.pulsion.com
ISIN:         DE0005487904
WKN:          548790
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------